Is Heron Therapeutics, Inc. FDA approved?

Heron Therapeutics, Inc. holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Heron Therapeutics, Inc. make?

5 products are listed under Heron Therapeutics, Inc. in the openFDA NDC Directory, most often as solution; emulsion; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Heron Therapeutics, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 5
Live patents: 91
Exclusivities: 1
Countries: 0

Catalogue

Drug listings by form and route

5 active NDC listings: 5 human prescription drug. By marketing category: NDA 5.

Dosage form	NDCs
solution	2
emulsion	1
injection	1
injection, emulsion	1

Route	NDCs
infiltration	2
intravenous	2
subcutaneous	1

Labeller name on the listing	NDCs
heron therapeutics, inc.	5

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
10398686	ZYNRELEF KITbupivacaine; meloxicam	product	Mar 2034
11253504	ZYNRELEF KITbupivacaine; meloxicam	use	Mar 2034
9592227	ZYNRELEF KITbupivacaine; meloxicam	product	Mar 2034
9744163	ZYNRELEF KITbupivacaine; meloxicam	product	Mar 2034
9913909	ZYNRELEF KITbupivacaine; meloxicam	use	Mar 2034
10098957	ZYNRELEF KITbupivacaine; meloxicam	use	Apr 2035
10213510	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
10632199	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
10898575	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
10980886	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
11083730	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
11083797	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
11413350	ZYNRELEF KITbupivacaine; meloxicam	use	Apr 2035
9694079	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
9801945	ZYNRELEF KITbupivacaine; meloxicam	product	Apr 2035
10500208	APONVIE, CINVANTIaprepitant	product	Sept 2035
10624850	APONVIE, CINVANTIaprepitant	use	Sept 2035
10953018	APONVIE, CINVANTIaprepitant	use	Sept 2035
11173118	APONVIE, CINVANTIaprepitant	product	Sept 2035
11744800	APONVIE, CINVANTIaprepitant	product	Sept 2035
11878074	APONVIEaprepitant	use	Sept 2035
12115254	APONVIE, CINVANTIaprepitant	product	Sept 2035
12115255	APONVIE, CINVANTIaprepitant	product	Sept 2035
12290520	APONVIE, CINVANTIaprepitant	product	Sept 2035
9561229	APONVIE, CINVANTIaprepitant	product	Sept 2035
9808465	APONVIE, CINVANTIaprepitant	use	Sept 2035
9974742	APONVIE, CINVANTIaprepitant	product	Sept 2035
9974793	APONVIE, CINVANTIaprepitant	product	Sept 2035
9974794	APONVIE, CINVANTIaprepitant	product	Sept 2035
11844837	ZYNRELEF KITbupivacaine; meloxicam	use	Apr 2036

Product	Exclusivity	Until
ZYNRELEF KITBUPIVACAINE; MELOXICAM	I-933 New indication	Jan 2027

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
APONVIE	APREPITANT	emulsion, intravenous	47426-401NDA
CINVANTI	aprepitant	injection, emulsion, intravenous	47426-201NDA
SUSTOL	granisetron	injection, subcutaneous	47426-101NDA
ZYNRELEF	BUPIVACAINE and MELOXICAM	solution, infiltration	47426-501NDA
ZYNRELEF	BUPIVACAINE and MELOXICAM	solution, infiltration	47426-503NDA

Enquiry

Common questions

Is Heron Therapeutics, Inc. FDA approved?: Heron Therapeutics, Inc. holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Heron Therapeutics, Inc. make?: 5 products are listed under Heron Therapeutics, Inc. in the openFDA NDC Directory, most often as solution; emulsion; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.